Carregant...
Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis
Emerging evidence suggests that alternative splicing (AS) is modified in cancer and is associated with cancer progression. Systematic analysis of AS signature in glioblastoma (GBM) is lacking and is greatly needed. We profiled genome-wide AS events in 498 GBM patients in TCGA using RNA-seq data, and...
Guardat en:
| Publicat a: | Front Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769083/ https://ncbi.nlm.nih.gov/pubmed/31608231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00928 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|